Literature DB >> 31676314

The SAFE-trial: Safe surgery for glioblastoma multiforme: Awake craniotomy versus surgery under general anesthesia. Study protocol for a multicenter prospective randomized controlled trial.

Jasper K W Gerritsen1, Markus Klimek2, Clemens M F Dirven3, Esther Oomen-de Hoop4, Michiel Wagemakers5, Geert Jan M Rutten6, Alfred Kloet7, Giorgio G Hallaert8, Arnaud J P E Vincent3.   

Abstract

BACKGROUND: Surgery of GBM nowadays is usually performed under general anesthesia (GA) and resections are often not as aggressive as possible, due to the chance of seriously damaging the patient with a rather low life expectancy. A surgical technique optimizing resection of the tumor in eloquent areas but preventing neurological deficits is necessary to improve survival and quality of life in these patients. Awake craniotomy (AC) with the use of cortical and subcortical stimulation has been widely implemented for low-grade glioma resections (LGG), but not yet for GBM. AC has shown to increase resection percentage and preserve quality of life in LGG and could thus be of important value in GBM surgery. METHODS/
DESIGN: This study is a prospective, multicenter, randomized controlled trial (RCT). Consecutive patients with a glioblastoma in or near eloquent areas (Sawaya grading II/III) will be 1:1 randomized to awake craniotomy or craniotomy under general anesthesia. 246 patients will be included in neurosurgical centers in the Netherlands and Belgium. Primary end-points are: 1) Postoperative neurological morbidity and 2) Proportion of patients with gross-total resections. Secondary end-points are: 1) Health-related quality of life; 2) Progression-free survival (PFS); 3) Overall survival (OS) and 4) Frequency and severity of Serious Adverse Effects in each group. Also, a cost-benefit analysis will be performed. All patients will receive standard adjuvant treatment with concomitant chemoradiotherapy. DISCUSSION: This RCT should demonstrate whether AC is superior to craniotomy under GA on neurological morbidity, extent of resection and survival for glioblastoma resections in or near eloquent areas. TRIAL REGISTRATION: Clinicaltrials.gov: NCT03861299 Netherlands Trial Register (NTR): NL7589.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Awake craniotomy; Extent of resection; Glioblastoma; Neurological morbidity; Quality of life

Mesh:

Year:  2019        PMID: 31676314     DOI: 10.1016/j.cct.2019.105876

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  4 in total

1.  What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?

Authors:  Anne Clavreul; Ghislaine Aubin; Matthieu Delion; Jean-Michel Lemée; Aram Ter Minassian; Philippe Menei
Journal:  J Neurooncol       Date:  2021-01-04       Impact factor: 4.130

2.  Impact of awake mapping on overall survival and extent of resection in patients with adult diffuse gliomas within or near eloquent areas: a retrospective propensity score-matched analysis of awake craniotomy vs. general anesthesia.

Authors:  Atsushi Fukui; Yoshihiro Muragaki; Taiichi Saito; Masayuki Nitta; Shunsuke Tsuzuki; Hidetsugu Asano; Takakazu Kawamata
Journal:  Acta Neurochir (Wien)       Date:  2021-10-04       Impact factor: 2.216

Review 3.  Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis.

Authors:  John J Y Zhang; Keng Siang Lee; Mathew R Voisin; Shawn L Hervey-Jumper; Mitchel S Berger; Gelareh Zadeh
Journal:  Neurooncol Adv       Date:  2020-09-18

4.  Can awake glioma surgery be the new standard of care in developing countries?

Authors:  Syed Sarmad Bukhari; M Shahzad Shamim
Journal:  Surg Neurol Int       Date:  2020-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.